Diabetic Tussin Sore Throat And Cough Cherry Lozenge
NDC Package 61787-070-15

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Diabetic Tussin Sore Throat And Cough Cherry (benzocaine and dextromethorphan hbr) lozenges is adults and children over 12 years of age: 2 lozenges every 4 hours – not to exceed 12 lozenges every 24 hours. This formulation utilizes a lozenge delivery system. Marketed by Medtech Products Inc, this product is identified by NDC 61787-070 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
61787-070-15
Package Description
3 BLISTER PACK in 1 CARTON / 5 LOZENGE in 1 BLISTER PACK
Product Code
61787-070
11-Digit Billing Format
61787007015
RxNorm Crosswalk
  • RxCUI: 1045532 - benzocaine 6 MG / dextromethorphan HBr 5 MG / menthol 10 MG Oral Lozenge
  • RxCUI: 1045532 - benzocaine 6 MG / dextromethorphan hydrobromide 5 MG / menthol 10 MG Oral Lozenge

Clinical Specifications

Proprietary Name
Diabetic Tussin Sore Throat And Cough Cherry
Non-Proprietary Name
Benzocaine And Dextromethorphan Hbr
Substance Name
Benzocaine; Dextromethorphan Hydrobromide; Menthol
Dosage Form
Lozenge - A solid preparation containing one or more medicaments, usually in a flavored, sweetened base which is intended to dissolve or disintegrate slowly in the mouth. A lollipop is a lozenge on a stick.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Adults and children over 12 years of age: 2 lozenges every 4 hours – not to exceed 12 lozenges every 24 hours. Children 6–12 years of age: Ask a doctor before use.Children under 6 years of age: Do not use.

Regulatory & Marketing

Labeler Name
Medtech Products Inc
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-20-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 61787-070-15 identifies a specific commercial package of 3 blister pack in 1 carton / 5 lozenge in 1 blister pack of Diabetic Tussin Sore Throat And Cough Cherry, a human over the counter drug labeled by Medtech Products Inc. This lozenge is formulated for oral use and contains benzocaine; dextromethorphan hydrobromide; menthol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medtech Products Inc on June 20, 2024. The current certification is valid through December 31, 2026.

How is this Medtech Products Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 61787007015. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
61787-070-15
11-Digit CMS (5-4-2)
61787-0070-15

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.